Skip to main content
Clinical Trials/ACTRN12616000992404
ACTRN12616000992404
Completed
未知

Effects of a lifestyle intervention in patients with Non-Alcoholic Fatty Liver Disease or Hepatitis C

Professor Jacob George0 sites180 target enrollmentJuly 28, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Professor Jacob George
Enrollment
180
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 28, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor Jacob George

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of non\-aldoholic fatty liver disease (NAFLD) or hepatitis C (and not receiving anti\-viral therapy)
  • Males and females aged 18 years and over
  • Elevated ALT U/L) (\>30 in males and \>19 in females)

Exclusion Criteria

  • Alcohol intake \>30g per day in males or \>20g per day in females
  • Current injecting drug use or unstable drug habit
  • Liver cancer
  • Severe Depression (HADDS Score)
  • Cushing's Syndrome
  • Chronic Pancreatitis
  • Other liver diseases identified by appropriate tests including Hepatitis B (negative for hepatitis B surface antigen), autoimmune liver disease (antinuclear antibody, antismooth muscle antibody, anti\-liver kidney microsomal antibody and antimitochondrial antibody), Wilson's disease (serum copper and ceruloplasmin levels), alpha\-1 antitrypsin deficiency (alpha\-1 antitrypsin deficiency (alpha\-1 antitrypsin levels and alpha\-1 antitrypsin genotype) and hemochromatosis (iron studies and genotyping for C268Y and H63D mutations).

Outcomes

Primary Outcomes

Not specified

Similar Trials